| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Algorithms | 25 | 2023 | 1913 | 2.810 |
Why?
|
| Image Processing, Computer-Assisted | 16 | 2025 | 1255 | 2.600 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2021 | 2677 | 2.560 |
Why?
|
| Phantoms, Imaging | 24 | 2017 | 462 | 1.780 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 9 | 2015 | 474 | 1.630 |
Why?
|
| Radiographic Image Enhancement | 8 | 2015 | 465 | 1.360 |
Why?
|
| Imaging, Three-Dimensional | 10 | 2025 | 603 | 1.340 |
Why?
|
| Microscopy | 3 | 2020 | 87 | 1.310 |
Why?
|
| Elasticity Imaging Techniques | 4 | 2010 | 57 | 1.290 |
Why?
|
| Acoustics | 5 | 2012 | 51 | 1.230 |
Why?
|
| Artifacts | 8 | 2023 | 246 | 1.200 |
Why?
|
| Tomography, Spiral Computed | 5 | 2004 | 77 | 1.040 |
Why?
|
| Spectrometry, X-Ray Emission | 3 | 2013 | 10 | 0.950 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2010 | 696 | 0.900 |
Why?
|
| Image Enhancement | 5 | 2010 | 565 | 0.900 |
Why?
|
| Sensitivity and Specificity | 19 | 2016 | 2018 | 0.850 |
Why?
|
| Photoacoustic Techniques | 2 | 2013 | 7 | 0.840 |
Why?
|
| Equipment Failure Analysis | 5 | 2013 | 91 | 0.780 |
Why?
|
| X-Ray Microtomography | 4 | 2023 | 91 | 0.750 |
Why?
|
| Microscopy, Fluorescence | 6 | 2025 | 434 | 0.730 |
Why?
|
| Reproducibility of Results | 18 | 2013 | 2767 | 0.720 |
Why?
|
| Tomography, Optical | 2 | 2010 | 9 | 0.680 |
Why?
|
| Radiation Dosage | 3 | 2016 | 230 | 0.630 |
Why?
|
| Synchrotrons | 2 | 2022 | 29 | 0.630 |
Why?
|
| Molecular Imaging | 1 | 2019 | 66 | 0.620 |
Why?
|
| Sharks | 1 | 2018 | 16 | 0.590 |
Why?
|
| Luminescence | 1 | 2017 | 21 | 0.590 |
Why?
|
| Signal Processing, Computer-Assisted | 5 | 2005 | 202 | 0.570 |
Why?
|
| Optical Imaging | 1 | 2017 | 51 | 0.560 |
Why?
|
| Computer Simulation | 7 | 2016 | 1102 | 0.540 |
Why?
|
| Scintillation Counting | 1 | 2015 | 5 | 0.520 |
Why?
|
| Tomography | 2 | 2012 | 21 | 0.490 |
Why?
|
| Zebrafish | 3 | 2020 | 322 | 0.490 |
Why?
|
| Fourier Analysis | 5 | 2013 | 128 | 0.480 |
Why?
|
| Tomography, X-Ray | 1 | 2014 | 18 | 0.470 |
Why?
|
| Likelihood Functions | 7 | 2015 | 252 | 0.460 |
Why?
|
| Tomography, Optical Coherence | 2 | 2022 | 137 | 0.430 |
Why?
|
| Particulate Matter | 1 | 2014 | 102 | 0.430 |
Why?
|
| Transducers | 2 | 2009 | 42 | 0.410 |
Why?
|
| Calibration | 3 | 2017 | 103 | 0.380 |
Why?
|
| Sample Size | 4 | 2004 | 125 | 0.360 |
Why?
|
| Metal-Organic Frameworks | 2 | 2022 | 15 | 0.350 |
Why?
|
| Molecular Probe Techniques | 1 | 2010 | 9 | 0.350 |
Why?
|
| Chlorophyll | 1 | 2010 | 47 | 0.350 |
Why?
|
| Biological Evolution | 1 | 2018 | 974 | 0.340 |
Why?
|
| X-Rays | 4 | 2022 | 137 | 0.340 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 101 | 0.340 |
Why?
|
| Optical Devices | 1 | 2009 | 1 | 0.330 |
Why?
|
| Light | 1 | 2010 | 292 | 0.330 |
Why?
|
| Models, Biological | 4 | 2014 | 1765 | 0.320 |
Why?
|
| Equipment Design | 4 | 2013 | 422 | 0.320 |
Why?
|
| Caenorhabditis elegans | 4 | 2025 | 231 | 0.320 |
Why?
|
| Ultrasonography, Mammary | 1 | 2009 | 83 | 0.310 |
Why?
|
| Genome | 1 | 2011 | 391 | 0.310 |
Why?
|
| Contrast Media | 2 | 2011 | 1084 | 0.310 |
Why?
|
| Numerical Analysis, Computer-Assisted | 2 | 2005 | 33 | 0.300 |
Why?
|
| Models, Statistical | 7 | 2012 | 576 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 663 | 0.280 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 476 | 0.270 |
Why?
|
| Photons | 2 | 2016 | 47 | 0.250 |
Why?
|
| Information Storage and Retrieval | 4 | 2006 | 121 | 0.240 |
Why?
|
| Humans | 28 | 2025 | 89968 | 0.240 |
Why?
|
| Microscopy, Confocal | 2 | 2025 | 280 | 0.240 |
Why?
|
| Tomography, Emission-Computed | 2 | 2005 | 102 | 0.240 |
Why?
|
| Arteriovenous Malformations | 1 | 2024 | 45 | 0.230 |
Why?
|
| Pulmonary Veins | 1 | 2024 | 93 | 0.220 |
Why?
|
| Ultrasonography | 1 | 2006 | 720 | 0.210 |
Why?
|
| Lighting | 1 | 2023 | 33 | 0.210 |
Why?
|
| Awareness | 1 | 2023 | 88 | 0.210 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 155 | 0.210 |
Why?
|
| Animals | 15 | 2025 | 27528 | 0.200 |
Why?
|
| Dinoflagellida | 1 | 2022 | 4 | 0.200 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 323 | 0.200 |
Why?
|
| Optical Phenomena | 2 | 2013 | 8 | 0.200 |
Why?
|
| Anthozoa | 1 | 2022 | 14 | 0.200 |
Why?
|
| Capillaries | 1 | 2022 | 90 | 0.200 |
Why?
|
| Absorption | 2 | 2012 | 25 | 0.190 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2003 | 139 | 0.190 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2023 | 109 | 0.190 |
Why?
|
| Embolization, Therapeutic | 1 | 2024 | 265 | 0.190 |
Why?
|
| Optics and Photonics | 2 | 2012 | 27 | 0.190 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 111 | 0.180 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 94 | 0.170 |
Why?
|
| Histological Techniques | 1 | 2019 | 36 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2019 | 115 | 0.160 |
Why?
|
| Mice | 10 | 2025 | 11851 | 0.160 |
Why?
|
| Quality Control | 3 | 2003 | 117 | 0.150 |
Why?
|
| Hyoid Bone | 1 | 2018 | 12 | 0.150 |
Why?
|
| Germany | 1 | 2018 | 73 | 0.150 |
Why?
|
| Gills | 1 | 2018 | 18 | 0.150 |
Why?
|
| Nanotechnology | 1 | 2018 | 68 | 0.150 |
Why?
|
| Tooth | 1 | 2018 | 51 | 0.150 |
Why?
|
| Cartilage | 1 | 2018 | 116 | 0.140 |
Why?
|
| Jaw | 1 | 2018 | 72 | 0.140 |
Why?
|
| Single Molecule Imaging | 1 | 2016 | 15 | 0.140 |
Why?
|
| Immunotherapy | 2 | 2022 | 698 | 0.130 |
Why?
|
| Materials Testing | 1 | 2016 | 93 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2018 | 332 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 278 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2017 | 164 | 0.130 |
Why?
|
| Normal Distribution | 2 | 2012 | 38 | 0.120 |
Why?
|
| Color | 1 | 2015 | 85 | 0.120 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2015 | 8 | 0.120 |
Why?
|
| Weight-Bearing | 1 | 2014 | 67 | 0.120 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 265 | 0.110 |
Why?
|
| Lung | 2 | 2011 | 1292 | 0.110 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2014 | 47 | 0.110 |
Why?
|
| Brain | 2 | 2021 | 2307 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 2587 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2014 | 131 | 0.110 |
Why?
|
| Head | 2 | 2004 | 137 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 271 | 0.110 |
Why?
|
| Least-Squares Analysis | 2 | 2010 | 48 | 0.110 |
Why?
|
| Phylogeny | 1 | 2018 | 1197 | 0.100 |
Why?
|
| Manganese Compounds | 1 | 2011 | 5 | 0.100 |
Why?
|
| Pressure | 1 | 2012 | 167 | 0.100 |
Why?
|
| Sphingolipids | 1 | 2011 | 20 | 0.100 |
Why?
|
| Shoulder | 1 | 2011 | 42 | 0.090 |
Why?
|
| Chlorides | 1 | 2011 | 104 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2011 | 41 | 0.090 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 70 | 0.090 |
Why?
|
| Sphingosine | 1 | 2011 | 74 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2011 | 66 | 0.090 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2010 | 24 | 0.090 |
Why?
|
| Time Factors | 4 | 2024 | 5359 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2013 | 785 | 0.090 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 45 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 277 | 0.090 |
Why?
|
| Lung Injury | 1 | 2010 | 53 | 0.080 |
Why?
|
| Simvastatin | 1 | 2010 | 105 | 0.080 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 17 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 899 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2010 | 161 | 0.080 |
Why?
|
| Glucose | 1 | 2011 | 629 | 0.080 |
Why?
|
| Nuclear Physics | 1 | 2008 | 17 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 696 | 0.080 |
Why?
|
| Electrodes | 1 | 2008 | 88 | 0.080 |
Why?
|
| Actins | 2 | 2025 | 462 | 0.070 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 408 | 0.070 |
Why?
|
| Skin | 1 | 2010 | 589 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3065 | 0.070 |
Why?
|
| Poisson Distribution | 2 | 2010 | 50 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 1469 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 377 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2006 | 117 | 0.070 |
Why?
|
| Vibration | 1 | 2006 | 50 | 0.060 |
Why?
|
| Xylem | 1 | 2025 | 1 | 0.060 |
Why?
|
| Microscopy, Polarization | 1 | 2025 | 11 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3475 | 0.060 |
Why?
|
| Radiometry | 1 | 2005 | 58 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1983 | 0.060 |
Why?
|
| Phenotype | 1 | 2011 | 2458 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2005 | 77 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 2370 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2008 | 584 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2009 | 493 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 48 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 90 | 0.060 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2024 | 99 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 324 | 0.050 |
Why?
|
| Choroid | 1 | 2022 | 36 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 113 | 0.050 |
Why?
|
| Coral Reefs | 1 | 2022 | 10 | 0.050 |
Why?
|
| Calcification, Physiologic | 1 | 2022 | 33 | 0.050 |
Why?
|
| Imaginal Discs | 1 | 2021 | 11 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2021 | 40 | 0.050 |
Why?
|
| Fluorescein Angiography | 1 | 2022 | 96 | 0.050 |
Why?
|
| Myoblasts | 1 | 2021 | 32 | 0.050 |
Why?
|
| Cell Line | 2 | 2020 | 2495 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2022 | 146 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 1131 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2023 | 195 | 0.050 |
Why?
|
| Radiography | 1 | 2023 | 808 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2003 | 225 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2005 | 332 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 141 | 0.050 |
Why?
|
| Software | 1 | 2005 | 669 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2021 | 277 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2021 | 511 | 0.040 |
Why?
|
| Symbiosis | 1 | 2022 | 127 | 0.040 |
Why?
|
| Anisotropy | 1 | 2000 | 63 | 0.040 |
Why?
|
| Connectome | 1 | 2021 | 76 | 0.040 |
Why?
|
| Temperature | 1 | 2022 | 409 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2000 | 305 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 156 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 9210 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2011 | 3252 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 1732 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2003 | 866 | 0.040 |
Why?
|
| Attention | 1 | 2023 | 395 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2000 | 591 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2018 | 35 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 136 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 476 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 210 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2017 | 77 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 397 | 0.040 |
Why?
|
| Septins | 1 | 2016 | 6 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2021 | 614 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2016 | 8 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2018 | 468 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 19254 | 0.030 |
Why?
|
| Male | 3 | 2024 | 42680 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2011 | 2015 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1091 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 309 | 0.030 |
Why?
|
| Female | 4 | 2024 | 46594 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 303 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2017 | 607 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1704 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26148 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 26822 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 6783 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 6410 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1718 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 8273 | 0.020 |
Why?
|
| Ceramides | 1 | 2011 | 35 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2011 | 37 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 127 | 0.020 |
Why?
|
| Adsorption | 1 | 2010 | 53 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2010 | 26 | 0.020 |
Why?
|
| Radiation Pneumonitis | 1 | 2010 | 21 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 38 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 341 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 81 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 1778 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 485 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 569 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2008 | 184 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3404 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 2331 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2008 | 314 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 684 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1158 | 0.020 |
Why?
|